Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-09

Clinical Trial Update: Intercostal Nerve Block With Liposome Bupivacaine in Subjects Undergoing Posterolateral Thoracotomy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating intercostal nerve block with liposome bupivacaine for postoperative pain after posterolateral thoracotomy has completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liposome bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Posterolateral Thoracotomy, Postoperative Pain | Phase 3 | Status: COMPLETED | Results posted: 2020-12-09